MELBOURNE, Fla., December 29, 2014 – LiveTV Satellite Communications, a Thales company and Greenwich AeroGroup, have achieved another joint milestone in inflight integration by demonstrating their LiveAero™ connectivity solution on a Sikorsky S-92® helicopter in-flight.
LiveTV Satellite Communications and distributor Greenwich AeroGroup were chosen by Sikorsky to install and deliver LiveAero’s system to Sikorsky S-92 custom-equipped helicopters to be used primarily for search and rescue missions. LiveAero is the only true global broadband connectivity system that is unaffected by helicopter rotors and weather. The system offers three voice and one data/Wi-Fi channels that can all simultaneously be used for voice, data and compressed video transmission anywhere around the globe on fixed wing and rotorcraft. The system can support critical mission data requirements such as texting, emails, internet surfing, aircraft health monitoring,VPN/Cloud connectivity, patient life signs/triage information and more during all stages of flights, on and offshore.
Thomas Tully, Engineering Project Manager for Sikorsky Aircraft, said, “We were able to demonstrate in flight that the Safe Triage System has the ability to capture and transmit all vital signs via wireless peripherals directly to emergency medical centers to aid in intelligent diagnosis.”
“This confirms that the technology provides the rotorcraft industry with a very stable, high availability data link,” said Thales LiveTV President Glenn Latta.
The Thales breakthrough uses a multi-element seven-panel phased-array antenna to communicate with Iridium’s network of 66 Low-Earth Orbit satellites (LEO) in orbit and manage the bandwidth between satellites. The flight testing included Iridium space vehicle passes at a variety of azimuths, showing continuous connectivity throughout the flight envelope.
About Thales
Thales is a global technology leader in the Aerospace, Transportation and Defence & Security markets. In 2013, the company generated revenues of €14.2 billion with 65,000 employees in 56 countries. With its 25,000 engineers and researchers, Thales has a unique capability to design, develop and deploy equipment, systems and services that meet the most complex security requirements. Thales has an exceptional international footprint, with operations around the world working with customers and local partners. The Group’s IFEC business was established in 1999 and today is a leading provider of award winning embedded and wireless passenger systems for the purpose of enriching the travel experience. Through the development of advanced applications for passengers and crews and wide range of connected services both in the air and on the ground, Thales IFEC services over 100 airlines located in all major regions of the world.
About Greenwich AeroGroup
Greenwich AeroGroup Inc., owns and operates providers of general, commercial, government and military aviation services including: maintenance, avionics and interior refurbishments; fixed base operations; aircraft sales, charter and management; manufacturing; component repair and overhaul; parts distribution and financial services. Current locations include: Aero Precision Industries, located in Livermore, Calif.; DAC International, located in Austin, Texas; Professional Aircraft Accessories, located in Titusville, Fla.; Professional Aviation Associates, located in Atlanta, Ga.; NASAM, located in South San Francisco, Calif.; Summit Aviation, located in Middletown, Del.; TruAtlantic Mfg., located in Kernersville, N.C.; and Western Aircraft, located in Boise, Idaho. Additionally, Greenwich AeroGroup owns an interest in Helivia Aero Taxi located in Rio de Janeiro. News and information are available at www.greenwichaerogroup.com.
About Triage Ltd
Safe Triage Ltd is a Birmingham based clinically led medical software company, focused on pre hospital care and telemedicine, using mobile communication to make healthcare safer, more efficient and user friendly. Its products are hardware agnostic, easily customizable, simple to deploy and all have been proven in the NHS.
